Vital Access, a provider of surgical and interventional technologies, has launched SAVE-2 post-market clinical follow-up study to investigate the benefits of VWING vascular needle guide for self-cannulation. The SAVE-2 study follows the ...
Vital Access, a manufacturer of surgical and interventional technologies, has secured the US Food and Drug Administration (FDA) market approval for its VWING device, a vascular needle guide developed to enable vascular access to ...
Tags: Vital Access, VWING device